| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
neuregulin 1 | 0.464 | 0.885 | 1.00 |
|
disease | 0.500 | None | 0.948 | 7 | 2 | 2002 | 2020 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.900 | limited | 0.865 | 5 | 0 | 2001 | 2019 | ||||||||
|
CUB and Sushi multiple domains 1 | 0.610 | 0.500 | 1.00 |
|
disease | 0.700 | None | 1.000 | 5 | 8 | 2011 | 2020 | ||||||||
|
zinc finger DHHC-type palmitoyltransferase 8 | 0.769 | 0.346 | 0.85 |
|
disease | 0.600 | None | 0.200 | 5 | 0 | 2004 | 2017 | ||||||||
|
nuclear receptor subfamily 4 group A member 2 | 0.529 | 0.846 | 1.00 |
|
disease | 0.600 | None | 0.800 | 5 | 0 | 1999 | 2020 | ||||||||
|
protein phosphatase 1 regulatory inhibitor subunit 1B | 0.617 | 0.500 | 0.24 |
|
disease | 0.600 | None | 1.000 | 5 | 0 | 2006 | 2019 | ||||||||
|
kynurenine 3-monooxygenase | 0.674 | 0.615 | 4.8E-05 |
|
disease | 0.600 | None | 0.800 | 5 | 0 | 2006 | 2018 | ||||||||
|
T-box transcription factor 1 | 0.433 | 0.808 | 0.84 |
|
disease | 0.500 | None | 1.000 | 5 | 1 | 1997 | 2017 | ||||||||
|
bromodomain containing 1 | 0.644 | 0.654 | 1.00 |
|
disease | 0.500 | None | 0.800 | 5 | 1 | 2006 | 2019 | ||||||||
|
forkhead box P2 | 0.545 | 0.808 | 1.00 |
|
disease | 0.500 | None | 0.800 | 5 | 1 | 2005 | 2019 | ||||||||
|
mediator complex subunit 12 | 0.476 | 0.769 | 1.00 |
|
disease | 0.490 | None | 0.800 | 5 | 0 | 2000 | 2010 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2A | 0.522 | 0.808 | 1.00 |
|
disease | 0.400 | None | 0.600 | 5 | 3 | 2003 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2001 | 2019 | ||||||||
|
frizzled class receptor 3 | 0.659 | 0.577 | 4.4E-04 |
|
disease | 0.400 | None | 0.400 | 5 | 0 | 2003 | 2016 | ||||||||
|
phospholipase A2 group IVA | 0.496 | 0.846 | 6.0E-05 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 1996 | 2019 | ||||||||
|
2',3'-cyclic nucleotide 3' phosphodiesterase | 0.604 | 0.692 | 0.98 |
|
disease | 0.400 | None | 0.400 | 5 | 0 | 2006 | 2018 | ||||||||
|
interleukin 4 | 0.332 | 0.962 | 4.7E-03 |
|
disease | 0.400 | None | 0.400 | 5 | 0 | 2003 | 2020 | ||||||||
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.674 | 0.538 | 5.8E-02 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 2006 | 2020 | ||||||||
|
oligodendrocyte transcription factor 2 | 0.560 | 0.577 | 9.5E-02 |
|
disease | 0.400 | None | 0.600 | 5 | 0 | 2006 | 2020 | ||||||||
|
myelin associated glycoprotein | 0.579 | 0.692 | 0.49 |
|
disease | 0.400 | None | 0.400 | 5 | 0 | 2004 | 2011 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
disease | 0.400 | None | 0.400 | 5 | 0 | 1994 | 2019 | ||||||||
|
somatostatin | 0.399 | 0.885 | 0.34 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2008 | 2020 | ||||||||
|
cholecystokinin A receptor | 0.615 | 0.500 | 4.0E-03 |
|
disease | 0.390 | None | 0.800 | 5 | 0 | 1999 | 2017 | ||||||||
|
interleukin 3 | 0.489 | 0.731 | 2.6E-09 |
|
disease | 0.380 | None | 1.000 | 5 | 0 | 2007 | 2018 | ||||||||
|
SRY-box transcription factor 10 | 0.461 | 0.808 | 0.99 |
|
disease | 0.380 | None | 1.000 | 5 | 0 | 2005 | 2014 |